Goldman Sachs Group »

Lb Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Lb Pharmaceuticals shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.4M 344k 15.79

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Spdr S&p 500 Etf Tr CMN (SPY)
Microsoft Corp CMN (MSFT)
Apple CMN (AAPL)
Invesco Qqq Tr CMN Put Option (QQQ)
Tesla CMN (TSLA)
Amazon CMN (AMZN)
Meta Platforms CMN (META)
Alphabet CMN (GOOGL)
Broadcom CMN (AVGO)
Ishares Tr CMN (IVV)
Ishares Tr CMN Put Option (IWM)
Vanguard Index Fds CMN (VOO)
Ishares Tr CMN Put Option (HYG)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Lb Pharmaceuticals

Deep Track Capital
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Jpmorgan Chase & Co
BlackRock
Balyasny Asset Management
Vivo Capital
Jennison Associates
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management
Soleus Capital Management

View all funds holding Lb Pharmaceuticals